IGMS
Price:
$1.27
Market Cap:
$77.50M
IGM Biosciences, Inc. operates as a biotechnology firm dedicated to advancing Immunoglobulin M (IgM) antibodies. These novel therapeutic agents are being developed for a broad spectrum of conditions, including various cancers, infectious ailments, and autoimmune and inflammatory disorders. The company's most advanced experimental treatment is IGM-2323, a bispecific IgM antibody. This candidate is currently in Phase 2 clinical trials, evaluating its efficacy for patients diagnosed with relapsed or refractory B cell Non-Hodgkin's lymphoma (NHL). In addition to its lead program, IGM Biosciences maintains an active pipeline of other IgM antibodies. IGM-8444, an IgM antibody, is presently undergo...[Read more]
Industry
Biotechnology
IPO Date
2019-09-18
Stock Exchange
NASDAQ
Ticker
IGMS
According to IGM Biosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is 16.11%. This represents a change of -100.84% compared to the average of -1908.71% of the last 4 quarters.
The mean historical ROE of IGM Biosciences, Inc. over the last ten years is -37.62%. The current 16.11% ROE has changed -142.83% with respect to the historical average. Over the past ten years (40 quarters), IGMS's ROE was at its highest in in the March 2019 quarter at 152.11%. The ROE was at its lowest in in the March 2025 quarter at -7577.65%.
Average
-37.62%
Median
35.89%
Minimum
-406.45%
Maximum
45.43%
Discovering the peaks and valleys of IGM Biosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 235.22%
Maximum Annual ROE = 45.43%
Minimum Annual Increase = -425.31%
Minimum Annual ROE = -406.45%
| Year | ROE | Change |
|---|---|---|
| 2024 | -406.45% | 235.22% |
| 2023 | -121.25% | -425.31% |
| 2022 | 37.27% | -17.95% |
| 2021 | 45.43% | 6.63% |
| 2020 | 42.60% | 7.37% |
| 2019 | 39.68% | 15.00% |
| 2018 | 34.50% | 26.41% |
The current ROE of IGM Biosciences, Inc. (IGMS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-163.48%
5-year avg
-80.48%
10-year avg
-37.62%
IGM Biosciences, Inc.’s ROE is greater than Jade Biosciences, Inc. (-51.34%), less than Quince Therapeutics, Inc. (1.82%), greater than Berkeley Lights, Inc. (-55.98%), greater than Surface Oncology, Inc. (-61.52%), greater than Landos Biopharma, Inc. (-61.86%), less than Insight Molecular Diagnostics Inc. (380.80%), greater than Reneo Pharmaceuticals, Inc. (0%), greater than Achilles Therapeutics plc (-41.05%), less than Heat Biologics, Inc. (28.83%), greater than Sigilon Therapeutics, Inc. (-74.73%),
| Company | ROE | Market cap |
|---|---|---|
| -51.34% | $548.77M | |
| 1.82% | $5.26M | |
| -55.98% | $86.61M | |
| -61.52% | $65.08M | |
| -61.86% | $71.68M | |
| 380.80% | $146.02M | |
| 0% | $60.84M | |
| -41.05% | $60.83M | |
| 28.83% | $61.07M | |
| -74.73% | $56.22M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IGM Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like IGM Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is IGM Biosciences, Inc.'s ROE?
How is the ROE calculated for IGM Biosciences, Inc. (IGMS)?
What is the highest ROE for IGM Biosciences, Inc. (IGMS)?
What is the 3-year average ROE for IGM Biosciences, Inc. (IGMS)?
What is the 5-year average ROE for IGM Biosciences, Inc. (IGMS)?
How does the current ROE for IGM Biosciences, Inc. (IGMS) compare to its historical average?